Physician profile
Jonathan S Black
NPI 1548463300
$9,057.62
in general payments reported to CMS, 2019-2025
9 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.68 · 2021: $4,218 · 2022: $2,275 · 2023: $1,395 · 2024: $415 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,381 · Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,381.25 |
| Food and Beverage | $1,165.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,027.97 | 2021-2025 | Delta, Na |
| Integra Lifesciences Corporation | $257.89 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $255.46 | 2025 | Phasix Mesh |
| Polynovo North America LLC | $165.68 | 2024 | Novosorb Btm |
| Access Pro Medical, LLC | $154.59 | 2025 | Matriderm |
| Depuy Synthes Sales INC. | $94.32 | 2025 | Trumatch |
| Medical Device Business Services, INC. | $53.60 | 2024 | Matrixcombo |
| Musculoskeletal Transplant Foundation INC. | $29.79 | 2024 | |
| Allergan, INC. | $18.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.